Energiot, a spin-off of the CSIC has developed a device to prevent the electrocution of birds on power lines and prevent accidents due to these causes.
Up to 59 groups, five of them from the CSIC, are part of the new TECNIO Association to promote technology transfer and connection with the business world. The Group of Chemical Transducers, GTQ, is one of the units with the TECNIO seal.
David Bricio has won the Best Poster Award in the JPhD2021, the 6th Scientific Meeting of PhD Students organized by PhD fellows of the ICMAB, IMB-CNM, ICN2 and the UAB. Marc Navarro, also at the IMB-CNM, won the second prize.
The Advanced Materials Cluster of Catalonia (Cluster MAV) is an organization that aims to promote and contribute to the competitiveness of companies and organizations in the advanced materials sector. The IMB-CNM has become a new member joining over 60 research institutions and companies, whilst providing unique capacities in silicon technologies.
Engineer Albert Alcacer has been awarded with the best oral presentation in the category of "Sensors, actuators and biomedical devices" in the last Spanish Conference on Electron Devices, which took place from 9th to 10th June.
The Societat Catalana de Nanociència i Nanotecnologia (SCN2) awards the first Dresselhaus Prize to María Jesús Ortiz i Aguayo, Chemistry graduate from the Universitat Autònoma de Barcelona (UAB), with a work reviewed by Dr. Maria del Mar Baeza Labat (UAB) and Dr. Gemma Gabriel Buguña (IMB-CNM).
The Chemical Transducers Group received the certificate in 2018 and is the only group within a CSIC centre in Catalonia with the distinction.
INBRAIN Neuroelectronics is a spin-off company of the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA. One of the founders is Anton Guimerà, researcher of the Group of Biomedical Applications at the Barcelona Institute of Microelectronics. INBRAIN has the mission to decode brain signals into medical solutions by developing intelligent neuroelectronic therapies based on graphene technology for application in patients with epilepsy, Parkinson’s and other brain related disorders.
